Sort
21,453 grants matching “tuberculosis”
Ontogeny and metabolism of lung alveolar macrophages in tuberculosis
$733,424Lu Huang · Univ Of Arkansas For Med Scis · R01 · FY2025 · AI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi
$733,356Philip C Hopewell · University Of California, San Francisco · R01 · FY2011 · AI
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
$733,212Abraham Pinter · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
$733,199David R Sherman · University Of Washington · R56 · FY2020 · AI
Post-TB epigenetic scars' impact on long-term inflammation, immunity and mortality
$733,050Andrew R Dinardo · Baylor College Of Medicine · R01 · FY2024 · AI
Columbia University-Southern African AIDS International Training/Research Program
$733,015Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2011 · TW
Mechanisms of vitamin A-dependent risk for tuberculosis progression and prevention
$732,939Brendan Podell · Colorado State University · R01 · FY2025 · AI
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$732,434Petros C Karakousis · Johns Hopkins University · R01 · FY2020 · AI
INHIBITION OF MYOCOLIC ACID BIOSYNTHESIS--M.TUBERCULOSIS
$732,377Yeshiva University · R01 · FY2000 · AI
Determining the performance and accuracy of SILVAMP TB LAM and cost-effectiveness of diagnostic testing for TB meningitis
$732,368Nathan Bahr · University Of Minnesota · R01 · FY2024 · AI
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
$732,235Lydia B Zablotska · University Of California, San Francisco · R01 · FY2016 · CA
Novel Methods to Inform HIV/TB Clinical Trial Development
$732,206Rochelle P Walensky · Massachusetts General Hospital · R37 · FY2018 · AI
Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection
$732,119John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2021 · AI
Columbia University-Southern African AIDS International Training/Research Program
$732,050Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2012 · TW
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid
$732,049Thuy Le · Duke University · R01 · FY2023 · AI
Membrane Protein Structures and Interactions in the M. tuberculosis Divisome
$731,861Timothy A Cross · Florida State University · R01 · FY2016 · AI
Membrane Protein Structures and Interactions in the M. tuberculosis Divisome
$731,754Timothy A Cross · Florida State University · R01 · FY2017 · AI
Rapid phenotypic detection of complex and emergent TB drug-resistance using a next-generation nanoluciferase reporter phage
$731,742Max O'Donnell · Columbia University Health Sciences · R01 · FY2025 · AI
Natural Resistance to Mycobacterium Tuberculosis Infection
$731,718W. Henry Henry Boom · Case Western Reserve University · U01 · FY2019 · AI
Microbial induction of sarcoidosis CD4+ T cell dysfunction
$731,710Wonder P. Drake · Vanderbilt University · R01 · FY2014 · HL
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP
$731,611Christopher J Lyon · Tulane University Of Louisiana · R01 · FY2023 · HD
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
$731,513Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2021 · AI
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
$731,513Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2019 · AI
Columbia University-Southern African AIDS International Training/Research Program
$731,474Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2010 · TW
Novel Methods to Inform HIV/TB Clinical Trial Development
$731,458Rochelle P Walensky · Massachusetts General Hospital · R37 · FY2016 · AI